Biotech leader John Maraganore has had a respected career in the industry, having built Alnylam Pharmaceuticals over 19 years into the leading RNAi therapeutics company in the world with five marketed RNAi medicines. He reflected on some of the current issues facing the biotech sector at the BIO CEO & Investor meeting in New York on 11 February – including the challenging economic climate, political changes in the US and competition from China.
Reflections From Biotech Leader John Maraganore
The founder and director of City Therapeutics and founding CEO of Alnylam discussed pressing issues facing the biotech sector in a fireside chat at the recent BIO CEO & Investor Conference.
